NYSE:MED - Medifast Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $171.25 -0.40 (-0.23 %) (As of 07/22/2018 08:47 AM ET)Previous Close$171.25Today's Range$167.81 - $173.0952-Week Range$41.24 - $179.52Volume133,271 shsAverage Volume159,915 shsMarket Capitalization$2.07 billionP/E Ratio61.38Dividend Yield1.12%Beta0.28 Company ProfileFinancialsAnalyst RatingsDividend HistoryEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by OPTAVIA, Flavors of Home, and Essential 1 brands. The company sells its products through various channels, including the Internet, call centers, independent health advisors, medical professionals, franchise weight loss clinics, and direct consumer marketing. As of December 31, 2017, it operated 16 franchised Medifast weight control centers in Arizona, California, Louisiana, Minnesota, and Wisconsin; and 18 reseller locations in California, Maryland, and Pennsylvania. The company was founded in 1980 and is headquartered in Baltimore, Maryland. Receive MED News and Ratings via Email Sign-up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Miscellaneous food preparations & kindred products Sub-IndustryPersonal Products SectorConsumer Staples SymbolNYSE:MED CUSIP58470H10 Webwww.medifast1.com Phone410-581-8042 Debt Debt-to-Equity RatioN/A Current Ratio3.43 Quick Ratio2.98 Price-To-Earnings Trailing P/E Ratio61.38 Forward P/E Ratio46.92 P/E Growth3.13 Sales & Book Value Annual Sales$301.56 million Price / Sales6.85 Cash Flow$2.7343 per share Price / Cash62.63 Book Value$9.10 per share Price / Book18.82 Profitability EPS (Most Recent Fiscal Year)$2.29 Net Income$27.72 million Net Margins10.26% Return on Equity31.11% Return on Assets24.07% Miscellaneous Employees399 Outstanding Shares12,060,000Market Cap$2,065.79 Medifast (NYSE:MED) Frequently Asked Questions What is Medifast's stock symbol? Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED." How often does Medifast pay dividends? What is the dividend yield for Medifast? Medifast announced a quarterly dividend on Friday, June 15th. Investors of record on Friday, June 29th will be paid a dividend of $0.48 per share on Wednesday, August 8th. This represents a $1.92 annualized dividend and a yield of 1.12%. The ex-dividend date of this dividend is Thursday, June 28th. View Medifast's Dividend History. How were Medifast's earnings last quarter? Medifast Inc (NYSE:MED) issued its earnings results on Thursday, May, 3rd. The specialty retailer reported $1.01 EPS for the quarter, beating the consensus estimate of $0.86 by $0.15. The specialty retailer earned $98.60 million during the quarter, compared to analyst estimates of $89.23 million. Medifast had a return on equity of 31.11% and a net margin of 10.26%. Medifast's revenue was up 39.7% compared to the same quarter last year. During the same period last year, the firm earned $0.36 EPS. View Medifast's Earnings History. When is Medifast's next earnings date? Medifast is scheduled to release their next quarterly earnings announcement on Thursday, August, 2nd 2018. View Earnings Estimates for Medifast. What guidance has Medifast issued on next quarter's earnings? Medifast issued an update on its FY18 earnings guidance on Thursday, May, 3rd. The company provided earnings per share (EPS) guidance of $3.55-3.65 for the period, compared to the Thomson Reuters consensus estimate of $3.24. The company issued revenue guidance of $385-395 million, compared to the consensus revenue estimate of $354.90 million.Medifast also updated its Q2 guidance to $0.94-0.97 EPS. What price target have analysts set for MED? 2 equities research analysts have issued 1-year price objectives for Medifast's stock. Their predictions range from $55.00 to $161.00. On average, they expect Medifast's stock price to reach $108.00 in the next twelve months. This suggests that the stock has a possible downside of 36.9%. View Analyst Ratings for Medifast. What is the consensus analysts' recommendation for Medifast? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." Who are some of Medifast's key competitors? Some companies that are related to Medifast include MCCORMICK & Co/SH SH NV (MKC), WANT WANT CHINA/ADR (WWNTY), Greencore Group (GNCGY), Farmer Bros (FARM), China Marine Food Group (CMFO) and Jammin Java (JAMN). Who are Medifast's key executives? Medifast's management team includes the folowing people: Mr. Daniel R. Chard, CEO & Director (Age 53)Mr. Timothy G. Robinson CPA, CPA, Chief Financial Officer (Age 56)Mr. Bill Baker, Exec. VP of Information Technology (Age 46)Mr. Jason L. Groves, Exec. VP, Gen. Counsel & Corp. Sec. (Age 47)Mr. Joseph Kelleman, VP of Fin. & Corp. Controller (Age 63) Has Medifast been receiving favorable news coverage? News stories about MED stock have trended somewhat positive recently, according to Accern Sentiment. The research group ranks the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Medifast earned a coverage optimism score of 0.15 on Accern's scale. They also assigned news headlines about the specialty retailer an impact score of 45.89 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days. Who are Medifast's major shareholders? Medifast's stock is owned by a variety of of institutional and retail investors. Top institutional investors include James Investment Research Inc. (0.14%), KAMES CAPITAL plc (0.10%), Municipal Employees Retirement System of Michigan (0.10%), Hartford Investment Management Co. (0.03%), First Citizens Bank & Trust Co. (0.02%) and Amalgamated Bank (0.02%). Company insiders that own Medifast stock include Charles P Connolly, Glenn W Welling, Jeffrey J Brown, Jeremy John Martin, Michael C Macdonald, Ralph Rushton and Simon TP Ridgway. View Institutional Ownership Trends for Medifast. Which institutional investors are selling Medifast stock? MED stock was sold by a variety of institutional investors in the last quarter, including KAMES CAPITAL plc, Municipal Employees Retirement System of Michigan and First Citizens Bank & Trust Co.. Company insiders that have sold Medifast company stock in the last year include Charles P Connolly, Glenn W Welling, Jeremy John Martin, Michael C Macdonald and Ralph Rushton. View Insider Buying and Selling for Medifast. Which institutional investors are buying Medifast stock? MED stock was bought by a variety of institutional investors in the last quarter, including James Investment Research Inc., Hartford Investment Management Co., Amalgamated Bank, Xact Kapitalforvaltning AB, Matisse Capital and Bank of Montreal Can. Company insiders that have bought Medifast stock in the last two years include Glenn W Welling, Jeffrey J Brown and Simon TP Ridgway. View Insider Buying and Selling for Medifast. How do I buy shares of Medifast? Shares of MED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Medifast's stock price today? One share of MED stock can currently be purchased for approximately $171.25. How big of a company is Medifast? Medifast has a market capitalization of $2.07 billion and generates $301.56 million in revenue each year. The specialty retailer earns $27.72 million in net income (profit) each year or $2.29 on an earnings per share basis. Medifast employs 399 workers across the globe. How can I contact Medifast? Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The specialty retailer can be reached via phone at 410-581-8042 or via email at [email protected] MarketBeat Community Rating for Medifast (NYSE MED)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 190 (Vote Outperform)Underperform Votes: 216 (Vote Underperform)Total Votes: 406MarketBeat's community ratings are surveys of what our community members think about Medifast and other stocks. Vote "Outperform" if you believe MED will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MED will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/22/2018 by MarketBeat.com StaffFeatured Article: What are Closed-End Mutual Funds?